NEW DRUGS IN THE PIPELINE: A REVIEW Journal title: International Journal of Medical Research & Health Sciences (IJMRHS) Authors: Dr Vivek Lal| Head, Medical Affairs, Gennova Biopharmaceuticals, Mumbai, Maharashtra corresponding a... Subject(s): Medicine, Biomedicine, Dentistry and Oral Surgery, Oncology, Public Health and Community Medicine
NASH: A glance at the landscape of pharmacological treatment Journal title: Annals of Hepatology Authors: Lucia Brodosi, Francesca Marchignoli, Maria Petroni, Giulio Marchesini Subject(s):
Journal title: International Research Journal of Pharmacy (IRJP) Authors: Hiren R Mehta , Paresh B Patel , Kamlesh C Patel , Tikson P Mazhvancherli Subject(s):
DAPAGLIFLOZIN: SELECTIVE SODIUM-GLUCOSE CO-TRANSPORTER-2 INHIBITOR IN TYPE 2 DIABETES Journal title: International Research Journal of Pharmacy (IRJP) Authors: Sudhakar Pemminati, Ashok Shenoy, Yugandhar B, Ullal SD, Ratnakar UP, Gopalakrishna HN, Preeth... Subject(s):
DAPAGLIFLOZIN: NEWER MOLECULE FOR TREATMENT OF TYPE 2 DIABETES MELLITUS Journal title: International Research Journal of Pharmacy (IRJP) Authors: Hiren R Mehta , Paresh B Patel , Kamlesh C Patel , Tikson P Mazhvancherli Subject(s):
Sodium Glucose Co-Transporter 2 (SGLT-2) Inhibitors: A Review Journal title: Journal of Medical Science And clinical Research Authors: Alok Dixit Subject(s):
EMPAGLIFLOZIN (SGLT2 INHIBITOR) IN TYPE 2 DIABETES MELLITUS Journal title: Journal of Evidence Based Medicine and Healthcare Authors: Mohammed Umar Farooque, Bharat Bhushan Subject(s):
Practice of Dapagliflozin Application in Patients with Type 2 Diabetes Mellitus Journal title: Міжнародний ендокринологічний журнал Authors: L.V. Shkala, Ya.I. Kleban, O.V. Cherpak, O.A. Karapetian, T.H. Volkovska Subject(s):
Canagliflozin – A Novel Oral Hyperglycemic Agent in The Fight Against Diabetic Mellitus Journal title: IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) Authors: S.Melina.I. Sahay, DamalKandadai Sriram, Melvin George Subject(s):
Dapagliflozin- Induced Severe Ketoacidosis Requiring Hemodialysis Journal title: Clinical Medical Reviews and Case Reports Authors: Subject(s):
A NEW STABILITY INDICATING RP-HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF ERTUGLIFLOZIN AND SITAGLIPTIN IN BULK AND PHARMACEUTICAL DOSAGE FORM ITS VALIDATION AS PER ICH GUIDELINES Journal title: Indo American Journal of Pharmaceutical Sciences Authors: Subject(s): Biological Sciences, Chemistry, Medicine, Analytical Chemistry, Pharmaceutical science - Pharmaceutical science
Marked Weight Loss, Muscle Wasting and Fatigue on Administration of Empagliflozin in a Subject with Type 2 Diabetes Journal title: Journal of Advances in Medicine and Medical Research Authors: Udaya M. Kabadi Subject(s):
Risk and Benefits of Canagliflozin, a New Sodium-Glucose Co-Transporter Type 2 Inhibitor, in the Treatment of type-2 Diabetes Mellitus Journal title: International Journal of Science and Research (IJSR) Authors: Subject(s):
The Combination of Canagliflozin with a Half-Dose of Glimepiride Improves Glycemic Control and Blood Glucose Perturbation without Increasing the Risk of Hypoglycemia and Ketosis Journal title: International Journal of Diabetes and Clinical Research Authors: Subject(s):
EFFECT OF SODIUM–GLUCOSE CO-TRANSPORT-2 (SGLT-2) INHIBITORS ON INTRA ORAL WOUND HEALING IN ALBINO RATS, AN EXPERIMENTAL STUDY Journal title: International Journal of Dental Research & Development (IJDRD) Authors: Subject(s):
